NCT02169544View on ClinicalTrials.gov

Post-marketing Study Assessing the Long-Term Safety of Abatacept

CompletedOBSERVATIONAL
Enrollment

100,000

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Abatacept

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT02169544 - Post-marketing Study Assessing the Long-Term Safety of Abatacept | Biotech Hunter | Biotech Hunter